Zevra Therapeutics Overview
Zevra Therapeutics Discounted Cash Flow
DCF Analysis for ZVRA.
Get informed when a big investor buys or sells
+ FollowFair Value
$-10.42
Current Fair Value
$-10.42
↓ 180.8% Downside
Overvalued by 180.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison